Single-Cell Sequencing Reveals that DBI is the Key Gene and Potential Therapeutic Target in Quiescent Bladder Cancer Stem Cells

Background: Drug resistance and recurrence often develop during the treatment of muscle-invasive bladder cancer (MIBC). The existence of cancer stem cells (CSCs) in MIBC makes the formulation of effective treatment strategies extremely challenging. We aimed to use single-cell RNA sequencing approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiaxi, Liu, Yue, Yang, Jitao, Li, Mengling, Li, Simin, Zhang, Bo, Yang, Rui, Zhang, Yuchong, Cui, Xiaoyu, Feng, ChunQing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235029/
https://www.ncbi.nlm.nih.gov/pubmed/35769986
http://dx.doi.org/10.3389/fgene.2022.904536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235029/
https://www.ncbi.nlm.nih.gov/pubmed/35769986
http://dx.doi.org/10.3389/fgene.2022.904536

Ejemplares similares